Zoetis(US:ZTS) ZACKSยท2025-06-18 23:16Company Performance - Zoetis (ZTS) closed at $155.06, reflecting a -4.09% change from the previous day, underperforming the S&P 500 which had a daily loss of 0.03% [1] - The stock has decreased by 1.21% over the past month, while the Medical sector gained 1.25% and the S&P 500 increased by 0.6% [1] Upcoming Financial Results - Zoetis is expected to report an EPS of $1.61, indicating a 3.21% increase from the same quarter last year, with projected revenue of $2.4 billion, a 1.67% rise from the previous year [2] - For the full year, earnings are projected at $6.26 per share and revenue at $9.49 billion, representing increases of +5.74% and +2.53% respectively from the prior year [3] Analyst Estimates and Rankings - Recent changes in analyst estimates for Zoetis are crucial as they reflect optimism about the business and profitability [3] - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), currently ranks Zoetis at 3 (Hold) [5] Valuation Metrics - Zoetis has a Forward P/E ratio of 25.85, which is a premium compared to the industry average Forward P/E of 16.43 [6] - The company also has a PEG ratio of 2.68, while the Medical - Drugs industry average PEG ratio is 1.67 [6] Industry Context - The Medical - Drugs industry, part of the Medical sector, holds a Zacks Industry Rank of 79, placing it in the top 33% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]